What is it about?
Glycated Albumin (GA) has potential value in the management of people with diabetes; however, to draw meaningful conclusions between clinical studies it is important that the GA values are comparable. This study shows the limitations of GA standardization when applied to the assessment of diabetes patients.
Featured Image
Read the Original
This page is a summary of: Limitations of glycated albumin standardization when applied to the assessment of diabetes patients, Clinical Chemistry and Laboratory Medicine (CCLM), June 2024, De Gruyter,
DOI: 10.1515/cclm-2024-0591.
You can read the full text:
Contributors
The following have contributed to this page